Aristides Capital’s Bausch Health BHC Stock Holding History

Aristides Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,639	Closed	-$199K	–	187
2025 Q4	$199K	Buy	+28,639	New	+$188K	0.04%	182

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aristides Capital's BHC Position: Q1 2026 in Review

Aristides Capital sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 28,639 shares — an estimated $199K sold.

Aristides Capital first reported a position in BHC in Q4 2025 and held it in 1 quarter. The position peaked at $199K in Q4 2025. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Aristides Capital reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Aristides Capital sold 28,639 Bausch Health shares in Q1 2026, an estimated $199K.
Aristides Capital first reported a position in Bausch Health in Q4 2025 and held it in 1 quarter.
Aristides Capital's Bausch Health position peaked at $199K in Q4 2025.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.